As an expert in the development of recombinant proteins for medical purposes, Dr Aldag presented the latest breakthrough of ciliate lipase, a recombinant enzyme being developed as a candidate for the treatment of exocrine pancreatic insufficiency. This innovative drug offers numerous advantages over current market standards such as CREON®.

In his Poster presentation, Dr. Aldag discussed the unique properties of Ciliate Lipase, including its effectiveness and crystallization characteristics.

The DDW is the world's leading educational forum for professionals in the field of gastroenterology.